Title : Survival in patients with pulmonary arterial hypertension treated with first-line bosentan.

Pub. Date : 2006 Sep

PMID : 16919005






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The oral dual endothelin (ET(A)/ET(B)) antagonist bosentan has been shown to improve exercise capacity, time to clinical worsening, haemodynamics and quality of life in short-term studies. Bosentan endothelin receptor type B Homo sapiens